본문 바로가기
KERD
논문KCI 등재

국민건강보험공단 청구자료를 활용한 파킨슨병과 관련된 코호트 연구 디자인 분석 및 향후 한의중재 관련 파킨슨 후향적 코호트 연구를 위한 제언

Current Research Status of National Health Insurance Database Studies in Korea Related to Parkinson’s Disease and Future Research Proposals for Integrative Therapies

임정태|황예채
대한예방한의학회 (Society of Preventive Korean Medicine)|2024.04|대한예방한의학회지 (Society of Preventive Korean Medicine)|제28권 제1호|pp. 69-87|DOI 10.25153/spkom.2024.28.1.006

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

Cohort StudyParkinson’s DiseaseNational Health Insurance Database Cohortnationwide longitudinal studyMortality rate
주제분류한의학

초록

Objectives : This study is to investigate the current National Health Insurance Database cohort studies related to complications of Parkinson’s Disease (PD) and suggest the design of Korean medical epidemiological studies of PD. Methods : Nationwide longitudinal studies of PD patients in South Korea were collected through Pubmed and the Korea Citation Index (KCI). We selected cohort studies that used the National Health Insurance Database in Korea and targeted Parkinson’s disease patients. Studies published before February 2024 were categorized according to study designs. We examined variables and covariates, enroll dates and matching methods. Results : Of a total of 536 studies, 18 studies met the inclusion criteria. All studies used the National Health Insurance (NHI) Research Database and among them, 5 used sample data and one senior database. Studies can be classified into two types. 11 cohort studies were comparing PD patients and non-PD patients. Another type was 4 PD patients cohort studies. Most studies used two diagnostic codes (G20 and V124) for inclusion criteria. Enroll periods were from 2002 to 2017, and follow-up periods were from 7 to 14 years. 16 studies considered age and sex as covariates. 15 studies used the propensity score matching method to increase the level of causality. There was only one study related to the Korean medical treatment. Conclusion : In future cohort studies on Korean medical treatment, more attempts should be made to reveal the effect of the treatments on PD patients by defining inclusion criteria for patient groups, covariates, exposure variables, and assessment indicators more operatively.

Abstract

Objectives : This study is to investigate the current National Health Insurance Database cohort studies related to complications of Parkinson’s Disease (PD) and suggest the design of Korean medical epidemiological studies of PD. Methods : Nationwide longitudinal studies of PD patients in South Korea were collected through Pubmed and the Korea Citation Index (KCI). We selected cohort studies that used the National Health Insurance Database in Korea and targeted Parkinson’s disease patients. Studies published before February 2024 were categorized according to study designs. We examined variables and covariates, enroll dates and matching methods. Results : Of a total of 536 studies, 18 studies met the inclusion criteria. All studies used the National Health Insurance (NHI) Research Database and among them, 5 used sample data and one senior database. Studies can be classified into two types. 11 cohort studies were comparing PD patients and non-PD patients. Another type was 4 PD patients cohort studies. Most studies used two diagnostic codes (G20 and V124) for inclusion criteria. Enroll periods were from 2002 to 2017, and follow-up periods were from 7 to 14 years. 16 studies considered age and sex as covariates. 15 studies used the propensity score matching method to increase the level of causality. There was only one study related to the Korean medical treatment. Conclusion : In future cohort studies on Korean medical treatment, more attempts should be made to reveal the effect of the treatments on PD patients by defining inclusion criteria for patient groups, covariates, exposure variables, and assessment indicators more operatively.

참고문헌 (54)

  1. Politis M, "Neuroimaging in Parkinson disease : from research setting to clinical practice", Nature Reviews Neurology, 10(12), pp.708~722 (2014)
  2. Raza C, "Parkinson’s disease : Mechanisms, translational models and management strategies", Life Sci, 226, pp.77~90 (2019)
  3. Sato K, "Prognosis of Parkinson’s disease : time to stage III, IV, V, and to motor fluctuations", Movement disord : official journal of the Movement Disord Society, 21(9), pp.1384~1395 (2006)
  4. Titlic M, "Side effects of ropinirole in patients with idiopathic Parkinson’s disease", Bratisl Lek Listy, 109(6), pp.273~275 (2008)
  5. Stern G, "The on-off effect-a sideeffect of long-term levodopa treatment", Nurs Mirror, 147(7), pp.17~18 (1978)
  6. Kim SR, "Use of complementary and alternative medicine by Korean patients with Parkinson’s disease", Clin Neurol Neurosurg, 111(2), pp.156~160 (2009)
  7. Lee SH, "Clinical effectiveness of acupuncture on Parkinson disease : A PRISMAcompliant systematic review and meta-analysis", Medicine, 96(3), pp.e5836~ (2017)
  8. Shan CS, "Herbal Medicine Formulas for Parkinson’s Disease : A Systematic Review and Meta-Analysis of Randomized Double-Blind Placebo-Controlled Clinical Trials", Front Aging Neurosci, 10, pp.349~ (2018)
  9. Kwon M, "Effect of Acupuncture on Movement Function in Patients with Parkinson’s Disease: Network Meta-Analysis of Randomized Controlled Trials", Healthcare(Basel), 9(11), pp.1502~ (2021)
  10. Woo YJ, "The Relation of Korean Medicine Services Use on the All-cause Mortality and Incidence of Parkinson’s disease and Elderly Patients with Chronic Disease in Korea", J Society of Preventive Korean Med, 25(3), pp.25~37 (2021)
  11. Lee YS, "Real-world data analysis on effectiveness of integrative therapies : A practical guide to study design and data analysis using healthcare databases", Integr Med Res, 12(4), pp.101000~ (2023)
  12. Leibson CL, "Comorbid conditions associated with Parkinson’s disease : a population-based study", Mov Disord, 21(4), pp.446~455 (2006)
  13. Macleod AD, "Comorbidity burden in Parkinson’s disease : Comparison with controls and its influence on prognosis", Parkinsonism Relat Disord, 28, pp.124~129 (2016)
  14. Arksey H, "Scoping studies : towards a methodological framework", International J of Social Research Methodology, 8(1), pp.19~32 (2005)
  15. Tricco AC, "PRISMA Extension for Scoping Reviews(PRISMA-ScR) : Checklist and Explanation", Ann Intern Med, 169(7), pp.467~473 (2018)
  16. Lee SH, "Region-Based Analysis of Prevalence and Incidence of Parkinson’s Disease : Analysis of the National Sample Cohort in South Korea", J Clin Neurol, 14(4), pp.478~486 (2018)
  17. Jeong SH, "Association between new-onset Parkinson’s disease and suicide risk in South Korea : a nationwide cohort study", BMC Psychiatry, 22(1), pp.341~ (2022)
  18. Kim WY, "Association of Parkinson’s disease with ischemic stroke in Korea : A nationwide longitudinal cohort study in Korea", J Cerebrovasc Endovasc Neurosurg, 23(3), pp.233~239 (2021)
  19. Cha S, "Dysphagia Requiring Medical Attention in Parkinson’s Disease : A Korean Population-Based Study", J Korean Med Sci, 38(15), pp.e114~ (2023)
  20. Kim TL, "Fracture risk and impact of osteoporosis in patients with Parkinson’s disease : a nationwide database study", J Bone Miner Metab, 40(4), pp.602~612 (2022)
  21. Nam JS, "Hip Fracture in Patients with Parkinson’s Disease and Related Mortality : A Population-Based Study in Korea", Gerontology, 67(5), pp.544~553 (2021)
  22. Ryu HJ, "Parkinson’s disease and skin cancer risk : a nationwide population-based cohort study in Korea", J Eur Acad Dermatol Venereol, 34(12), pp.2775~2780 (2020)
  23. Won JH, "Pneumonia risk and its associated factors in Parkinson’s disease : A National Database Study", J Neurol Sci, 415, pp.116949~ (2020)
  24. Won JH, "Risk and mortality of aspiration pneumonia in Parkinson’s disease : a nationwide database study", Sci Rep, 11(1), pp.6597~ (2021)
  25. Kim J, "Association between Parkinson’s Disease and Congestive Heart Failure in Korea: A Nationwide Longitudinal Cohort Study", J Pers Med, 13(9) (2023)
  26. Yoon SY, "The mortality rate of Parkinson’s disease and related comorbidities : a nationwide population-based matched cohort study in Korea", Age Ageing, 50(4), pp.1182~1188 (2021)
  27. Yoon SY, "Effects of socioeconomic status on mortality after Parkinson’s disease : A nationwide population-based matched cohort study in Korean populations", Parkinsonism Relat Disord, 80, pp.206~211 (2020)
  28. Sheen SH, "The Relationship between Parkinson’s Disease and Acute Myocardial Infarction in Korea : A Nationwide Longitudinal Cohort Study", J Korean Neurosurg Soc, 65(4), pp.507~513 (2022)
  29. Kim A, "Mortality of Deep Brain Stimulation and Risk Factors in Patients With Parkinson’s Disease : A National Cohort Study in Korea", J Korean Med Sci, 38(3), pp.e10~ (2023)
  30. Yoon SY, "Association between smoking and all-cause mortality in Parkinson’s disease", NPJ Parkinsons Dis, 9(1), pp.59~ (2023)
  31. Woo Y, "Effectiveness of Integrative Therapy for Parkinson’s Disease Management", Front Aging Neurosci, 11, pp.40~ (2019)
  32. Yun SJ, "Statin use and pneumonia risk in Parkinson’s disease", Parkinsonism Relat Disord, 91, pp.124~127 (2021)
  33. Lee T, "Increased suicide risk and clinical correlates of suicide among patients with Parkinson’s disease", Parkinsonism Relat Disord, 32, pp.102~107 (2016)
  34. Erlangsen A, "Association Between Neurological Disorders and Death by Suicide in Denmark", JAMA, 323(5), pp.444~454 (2020)
  35. Saito M, "Social disconnection and suicide mortality among Japanese older adults : A seven-year followup study", Social Science & Medicine, 347, pp.116778~ (2024)
  36. Zhang A, "Acupuncture for the Treatment of Neuropsychiatric Symptoms in Parkinson’s Disease : A Systematic Review and Meta-Analysis", Complement Ther Med, 80, pp.103020~ (2024)
  37. Hsu WT, "Acupuncture Improves Sleep Disorders and Depression among Patients with Parkinson’s Disease: A Meta-Analysis", Healthcare (Basel), 11(14) (2023)
  38. Watanabe H, "Parkinson’s Disease: Cells Succumbing to Lifelong Dopamine-Related Oxidative Stress and Other Bioenergetic Challenges", Int J Mol Sci, 25(4) (2024)
  39. Vogiatzi G, "The role of oxidative stress in atherosclerosis", Hellenic J Cardiol, 50(5), pp.402~409 (2009)
  40. Yin R, "The Positive Role and Mechanism of Herbal Medicine in Parkinson’s Disease", Oxid Med Cell Longev, 2021, pp.9923331~ (2021)
  41. Huang L, "Traditional Chinese Medicine for non-motor symptoms in Parkinson disease : A systematic review and meta-analysis of RCTs", Medicine(Baltimore), 102(30), pp.e34425~ (2023)
  42. Bosch G, "Dysphagia in hospitalized patients : Prevalence, related factors and impact on aspiration pneumonia and mortality", Eur J Clin Invest, 53(4), pp.e13930~ (2023)
  43. Almirall J, "Aspiration pneumonia : A renewed perspective and practical approach", Respir Med, 185, pp.106485~ (2021)
  44. Wu J, "A systematic review and meta-analysis of acupuncture in Parkinson’s disease with dysphagia", Front Neurol, 14, pp.1099012~ (2023)
  45. Lima DP, "Falls in Parkinson’s disease : the impact of disease progression, treatment, and motor complications", Dement Neuropsychol, 16(2), pp.153~161 (2022)
  46. Malochet-Guinamand S, "Parkinson’s disease : A risk factor for osteoporosis", Joint Bone Spine, 82(6), pp.406~410 (2015)
  47. Chen YY, "Parkinson’s disease and risk of hip fracture : an 8-year follow-up study in Taiwan", Parkinsonism Relat Disord, 18(5), pp.506~509 (2012)
  48. Chen KY, "Utilization of Chinese herbal medicine and its association with the risk of fracture in patients with Parkinson’s disease in Taiwan", J Ethnopharmacol, 226, pp.168~175 (2018)
  49. Inzelberg R, "Are Parkinson disease patients protected from some but not all cancers?", Neurology, 69(15), pp.1542~1550 (2007)
  50. Marras C, "Survival in Parkinson disease", Neurology, 64(1), pp.87~93 (2005)
  51. Kleiner-Fisman G, "Subthalamic nucleus deep brain stimulation : summary and meta-analysis of outcomes", Mov Disord, 14, pp.S290~S304 (2006)
  52. Mackenbach JP, "Socioeconomic inequalities in health in 22European countries", N Engl J Med, 358(23), pp.2468~2481 (2008)
  53. Kim SY, "Longitudinal study of the inverse relationship between Parkinson’s disease and cancer in Korea", NPJ Parkinsons Dis, 9(1), pp.116~ (2023)
  54. Park JH, "Cancer risk in patients with Parkinson’s disease in South Korea : A nationwide, population-based cohort study", Eur J Cancer, 117, pp.5~13 (2019)

이 간행물의 다른 논문 (10건)

한의약 건강돌봄 교육 프로그램에 대한 한의사 요구도 조사안은지, 이지현, 성동민, 강지혜, 한유진, 김동수pp. 1-11호주의 보완의학 현황에 관한 연구고요한, 임병묵pp. 13-30의료기기 허가⋅신고⋅심사 등에 관한 규정 변화와 전망 : 한의 의료기기 중심으로김대진, 강우석, 김태영, 정성희, 최병희pp. 31-42Flipped learning을 활용한 의료인문학 수업의 한의학과 학생에 대한 영향정아람, 정예훈, 이혜윤pp. 43-57한방의료 경험자의 첩약 복용 의향의 결정요인에 관한 연구김재우, 강정규, 김성호pp. 59-67
원문 보기